Menlo Park, CA, United States of America

William J Dower

USPTO Granted Patents = 76 

Average Co-Inventor Count = 3.5

ph-index = 39

Forward Citations = 9,768(Granted Patents)


Inventors with similar research interests:


Company Filing History:


Years Active: 1995-2024

Loading Chart...
76 patents (USPTO):

Title: The Innovative Contributions of William J Dower

Introduction

William J Dower, based in Menlo Park, California, is a prominent inventor known for his extensive work in the field of immunology and therapeutics. With an impressive portfolio of 76 patents, he has made significant contributions to various medical advancements, particularly in immunoglobulin fusion proteins.

Latest Patents

Dower's latest patents revolve around IL-7R agonists, which are crucial in immunological treatment. The patents include the disclosure of IL-7Rαγc ligand immunoglobulin fusion proteins and IL-7Rαγc IgG-Fc fusion proteins. These innovations highlight the potential of IL-7Rαγc ligands as effective agents in the treatment of various diseases. Moreover, his patents on IL-7R-α-γ binding compounds and related pharmaceutical compositions indicate their utility in addressing cancer, viral infections, autoimmune conditions, and inflammatory diseases.

Career Highlights

Throughout his career, William J Dower has been associated with leading organizations in the biotechnology sector. He has worked with Affymax Technologies and Affymetrix, Inc., where his research has significantly advanced understanding in his field. His extensive experience contributes to his ability to innovate and create impactful solutions in biomedicine.

Collaborations

Dower’s success is also attributed to fruitful collaborations with notable coworkers such as Ronald W Barrett and Steven E Cwirla. These partnerships have fostered an environment of shared knowledge and innovation, leading to breakthroughs in immunological therapies.

Conclusion

William J Dower stands out as an influential inventor whose work continues to shape the landscape of immunology and therapeutic development. With a strong focus on IL-7R agonists, his patents pave the way for new treatment modalities that can effectively combat various diseases, further underscoring his significance in the field of innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…